In addition, CPC specializes in the production of lanreotide therapy on an industrial scale, following the CGMP's (Current Good Manufacturing Practices). Our expertise allows us to manufacture a range of high-quality generic peptides at a commercial scale. With stringent quality control measures in place, we ensure consistent and reliable production of generic peptides that meet regulatory standards. Our Generic API Portfolio: Disease Area API Indication DMF Status Tumour Leuprorelin Acetate Prostate & Breast Cancer; Endometriosis; Uterine Leiomyomata; Precocious Puberty MFDS: 20200625-210-J-661 NMPA: Y20190007496(A) TFDA: 110DMF050097 Triptorelin Acetate Prostate & Breast Cancer; Endometriosis; Uterine Leiomyomata; Assisted Reproduction NMPA: Y20170001090(A) Goserelin Acetate Suppress production of the sex hormones NMPA: Y20230000413 Triptorelin Pamoate Endometriosis; Uterine Fibroids; Premature Puberty; Prostate Cancer; ART. NMPA：2024 Q2 Procreation Cetrorelix Acetate In Vitro Fertilization (IVF) NMPA: Y20190001147(A) FDA: 034884 Diabetes Exenatide Acetate Exenatide is an injectable diabetes medicine that helps control blood sugar levels. This medication helps pancreas produce insulin more efficiently NMPA: 2015/12 NMPA: Y20170001378 Semaglutide Type ll diabetes DMF： 2024 Q1 NMPA： 2024 Q1 Tirzepatide Type ll diabetes Early R&D Gastrointestinal Terlipressin Acetate An analogue of vasopressin, prescribed for bleeding esophageal varices, septic shock, hepatorenal syndrome and in management of low blood pressure NMPA:Y20200000281(A) CEP : 2020-111 ASMF: The Nethelands (03883) ASMF: Germany (4388) EDQM: R0-CEP 2020-111 Linaclotide lrritable Bowel Syndrome with Constipation (IBS-C): Chronic Idiopathic Constipation (CIC) NMPA：Y20210000906 Teduglutide A prescription medicine for adults with Short Bowel Syndrome who need additional nutrition or fluids fromIV feeding DMF：2024 Q4 Immunology Difelikefalin Treatment of moderate-to-severe pruritus associated with chronic kidney disease(CKD-aP; uremic pruritus) in adults undergoing hemodialysis NMPA：2025 Q1 As a peptide synthesis manufacture, we provide generic lanreotide,
, polypeptide cdmo
